Reverberations for Ebos in Chemist Warehouse reverse listing

Reverberations for Ebos in Chemist Warehouse reverse listing
Sigma shareholders might well ask themselves if they're paying too much. (Image: NZME)
Paul McBeth
Discount pharmacist Chemist Warehouse’s reverse takeover of drugmaker Sigma Healthcare to build Australia’s biggest pharmacy group won’t immediately dent Ebos Group and may even offer some opportunities down the road. The discount pharmacist found its route onto the Australian securities exchange (ASX) via a reverse listing of Sigma, where Sigma will borrow A$1 billion (NZ$1.07b) from ANZ and National Australia Bank, give A$700m of that to the Chemist Warehouse shareholders and issue them shares equivalent to 85.8% of the...

More Markets

BHP CEO flies to South Africa to push $65.4 billion takeover
Markets

BHP CEO flies to South Africa to push $65.4 billion takeover

The executives have already begun conversations with key stakeholders.

Rakon shareholder wants light shed on $400m bid
Markets

Rakon shareholder wants light shed on $400m bid

US giant Skyworks could be Rakon's new owner. One shareholder wants it to confirm.

BNZ ekes out gains in market share as 1H deposits and loans lift
Economy

BNZ ekes out gains in market share as 1H deposits and loans lift

The cost-to-income ratio was 36.2% versus 32.5% in the same period a year earlier.